Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8917621 | 0.98 | CFTR (0.34) | CFTRGOPC | |
| SCHEMBL4709428 | 0.78 | GSTP1 (0.36) | CYP2A6 | |
| SCHEMBL3244825 | 0.74 | GSTP1 (0.34) | — | |
| SCHEMBL10474054 | 0.72 | MAOA (0.34) | — | |
| SCHEMBL18849437 | 0.70 | — | — | |
| SCHEMBL31656985 | 0.68 | ALDH1A1 (0.38) | — | |
| SCHEMBL31657027 | 0.68 | ALDH1A1 (0.38) | — | |
| SCHEMBL31657085 | 0.68 | ALDH1A1 (0.38) | — | |
| SCHEMBL6828416 | 0.66 | BACE1 (0.43) | — | |
| SCHEMBL2230292 | 0.66 | MAPT (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-110198949-B | Process for the preparation of 9 beta, 10 alpha-progesterone (retroprogesterone) | 工业化学有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-107188874-A | A kind of synthetic method of chiral quaternary carbon compound | 浙江工业大学 | 2017-09-22 | — | — | CN | claimed |
| EP-2961374-B1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | claimed |
| CN-103709162-B | Tri-substituted imidazole benzodiazine ketonic compound and its production and use | 中国科学院上海药物研究所 | 2016-12-07 | — | — | CN | claimed |
| WO-1998029136-A1 | STABILIZED TRICYCLIC COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-07-09 | — | — | WO | claimed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| CN-116036278-B | Compositions and methods for treating cancers with atypical BRAF mutations | 生物医学谷探索股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-20240287406-A1 | FRAGRANCE COMPOSITION | COTY INC. | 2024-08-29 | — | — | US | disclosed |
| EP-4362924-A1 | FRAGRANCE COMPOSITION | Coty Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-1492795-A1 | 1- OR 3-THIA-BENZONAPHTHOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCTION AND INTERMEDIATES FOR THE PREPARATION THEREOF | PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003084961-A1 | 1- OR 3-THIA-BENZONAPHTHOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCTION AND INTERMEDIATES FOR THE PREPARATION THEREOF | PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) | 2003-10-16 | — | — | WO | disclosed |
| WO-1998029136-A1 | STABILIZED TRICYCLIC COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-07-09 | — | — | WO | disclosed |
| US-5770382-A | RETINOIC ACID AND RETINOID X RECEPTOR AGONISTS; TREATINGSKIN, EYE, BRAIN, AND CARDIOVASCULAR DISORDERS; CANCER | LIGAND PHARMACEUTICALS, INC. (US) | 1998-06-23 | — | — | US | disclosed |
| US-5770378-A | A VITAMINE A METABOLITE, POTENT DRUGS TREATING SKIN DISEASES, CANCER, EYE DISEASES, CARDIOVASCULAR DISORDERS | LIGAND PHARMACEUTICALS, INC. (US) | 1998-06-23 | — | — | US | disclosed |
| US-5770383-A | ACTIVATE RETINOID RECEPTORS | LIGAND PHARMACEUTICALS, INC. (US) | 1998-06-23 | — | — | US | disclosed |
| EP-0049953-B1 | 4-(SUBSTITUTED PHENYL)-NAPHTHALEN-2(1H)-ONES AND 2-OLS, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PFIZER INC. (US) | 1984-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | CFTR 1563/4885GOPC 2298/4885CYP2A6 4003/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | CFTR 2608/4885GOPC 3212/4885CYP2A6 1896/4885 |
| US-20240287406-A1 | FRAGRANCE COMPOSITION | FAAH2, FAAH, C1S | CFTR 2164/4885GOPC 3557/4885CYP2A6 858/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | CFTR 672/4885GOPC 984/4885CYP2A6 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.